Correction: Combined CHK1 and PD-L1 blockade as a novel therapeutic strategy against stemness and immunosuppression in ovarian cancer

Cancer Immunology Immunotherapy 2026 Open access

Read full text

Authors: Mengqing Chen, Lin Huang, Mengna Zhu, Jing Cai, Feiquan Ying, Lin Liu, Wenhan Li, Si Sun, Yuetao Wen

DOI: 10.1007/s00262-026-04314-1

Cited by: 0

Fields of Study & Subjects

Cancer Immunotherapy and Biomarkers Ovarian cancer diagnosis and treatment PARP inhibition in cancer therapy